Overview

Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

Status:
Recruiting
Trial end date:
2026-02-28
Target enrollment:
0
Participant gender:
All
Summary
For this protocol, the investigators plan to conduct a pilot study evaluating the effect of propranolol on alcohol consumption. Using a parallel design, the investigators plan to randomize 20 non-treatment seeking adults with alcohol use disorders (DSM-5) to propranolol extended release (160mg/day or placebo; n=10 per cell) to evaluate whether propranolol reduces alcohol self-administered in the laboratory. Importantly, the investigators will evaluate whether propranolol counteracts stress-induced effects on alcohol self-administration. Following titration to steady state medication levels over a 2-week period, each subject will complete two laboratory sessions consisting of a well validated method for inducing stress or neutral/relaxing state (order counterbalanced), followed by a 2-hour alcohol self-administration paradigm known to be sensitive to medication effects.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
Adrenergic beta-Antagonists
Propranolol
Criteria
Inclusion Criteria:

1. Age 21-65

2. Able to read and write English

3. Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for
current (past 6 months) alcohol use disorders

4. Able to take oral medications and willing to adhere to medication regimen

Exclusion Criteria:

1. Participants with any significant current medical conditions.

2. Women who are pregnant or nursing, or fail to use one of the following methods of
birth control unless she or partner is surgically sterile or she is postmenopausal
(hormone contraceptives [oral, implant, injection, patch, or ring], contraceptive
sponge, double barrier [diaphragm or condom plus spermicide], or IUD)

3. Suicidal, homicidal or evidence of current (past 6-month) mental illness.

4. Specific exclusions for administration of propranolol not already specified.

5. Subjects likely to exhibit clinically significant alcohol withdrawal during the study.